When will Beam Therapeutics submit a BLA for Risto-cel?
As of Fri, 20 Nov 2026 12:04:07 UTC, Kalshi traders price before April 2027 (84.0%), before 2027 (49.0%), before December (9.0%). The market has $31K in volume and closes on Thu, 01 Apr 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| before April 2027 | 84.0% | 84.0¢ | 16.0¢ |
| before 2027 | 49.0% | 49.0¢ | 51.0¢ |
| before December | 9.0% | 9.0¢ | 91.0¢ |
Market details
- Venue: Kalshi
- Volume: $31K
- Liquidity: $31K
- Closes:
Sources
Related markets
- When will the FDA reclassify BPC-157 to Category 1?
- Will the FDA approve retatrutide?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- Will the U.S. confirm that aliens exist?
- Best AI at the end of 2026?
- When will Anthropic release Mythos?
More markets like this
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will the FDA approve a cure for Type 1 diabetes before 2033?
- Will the FDA approve CagriSema?
- When will Beaver Creek Resort open for the 26/27 winter season?
- When will Big Sky open for the 26/27 winter season?
- When will Birch and Swinnerton-Dyer be resolved?
- When will Blue Origin's New Glenn rocket launch?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.